In an HF outpatient clinic, B-lines were significantly correlated with more established parameters of decompensation. A B-line ≥15 cutoff could be considered for a quick and reliable assessment of decompensation in outpatients with HF.
SummaryBackground: Inappropriate and subtherapeutic anticoagulants dosages may result in severe thromboembolic and bleeding complications. The use of this treatment requires special attention and strict clinical and laboratory follow-up.
Electronic records may contribute to the implementation of the nursing process, particularly if the identified signs and symptoms are documented and then linked to nursing diagnoses and interventions.
Our purpose is to characterize the profile of patients with Acute Coronary Syndrome (ACS) assisted in an emergency service in Porto Alegre. The characterization of the profiles focus on risk factors. This prevalence study was carried out from August, 2007 to February 2008. To collect the data, we developed a questionnaire, checked bedside assessment and measured anthropometric evaluation. 152 patients had their ACS evaluated, of which 63.8% were males, with an average age of 61 +/- 10.26 years. 50.7% had acute myocardial infarction non-ST elevation, 14.5% acute myocardial infarction with-ST elevation, and 34.9% unstable Angina. Risk factors were sedentariness (86.8%); overweightness and obesity (77%); systemic arterial hypertension (75.7%); family history (56.6%); stress (52.6%); dyslipidemia (44.7%); diabetes mellitus (40.1%); tobacco smoking (39.5%); and alcohol consumption (14.4%). A high prevalence of risk factors for ACS was verified, indicating a necessity of health education programs to reduce morbimortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.